Decreased interleukin-10 and increased interleukin- 12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

A. H.H. Van Boxel-Dezaire, S. C.J. Hoff, B. W. Van Oosten, C. L. Verweij, A. M. Dräger, H. J. Adèr, J. C. Van Houwelingen, F. Barkhof, C. H. Polman, L. Nagelkerken*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

It has been shown that proinflammatory and antiinflammatory cytokines correlate with disease activity in multiple sclerosis (MS). To establish whether such correlations depend on the disease stage, we assessed in a longitudinal fashion the expression of interleukin (IL)-12 (p40 and p35), tumor necrosis factor- 1/4 , interferon-γ, and IL-10 mRNA by competitive polymerase chain reaction in unstimulated peripheral blood mononuclear cells of relapsing-remitting (RR) and secondary progressive (SP) MS patients, in relation to monthly clinical and magnetic resonance imaging monitoring. MS patients had increased levels of IL-12p40 and decreased levels of IL-10 mRNA compared with controls; this difference was most pronounced in SP patients. Both RR and SP patients had increased levels of IL-12p40 mRNA compared with controls during the development of active lesions. Moreover, in RR MS an increase was found before relapse. IL-12p35 mRNA was decreased in both groups, and in relation to disease activity it showed a pattern different from IL-12p40 mRNA. In RR MS, IL-10 mRNA was low 4 weeks before magnetic resonance imaging activity and 6 weeks before relapse; a significant increase to normal levels was noted when active lesions became apparent. In contrast, SP patients showed low IL-10 mRNA levels constitutively, suggesting that IL- 10 plays an important role in the control of disease progression.

Original languageEnglish
Pages (from-to)695-703
Number of pages9
JournalAnnals of Neurology
Volume45
Issue number6
DOIs
Publication statusPublished - 15 Jun 1999

Cite this